Skip to main navigation

Skip to content

Search for:

About
Technology
Pipeline
Products
- XIPERE®
Investors

Investor Menu

IR Overview
News
Events and Presentations
Governance
SEC Filings
Financial Info
Resources

News

Year

Nov 13 2023

Clearside Biomedical Announces Third Quarter 2023 Financial Results and Provides Corporate Update

Nov 8 2023

Clearside Biomedical to Participate in Fireside Chat at the Stifel 2023 Healthcare Conference

Nov 7 2023

Clearside Biomedical’s Versatile Suprachoroidal Injection Platform Highlighted in Four Ophthalmic Indications in Clinical Data Presentations at AAO 2023 Annual Meeting

Nov 3 2023

BioCryst and Clearside Biomedical Enter Partnership to Develop Avoralstat for Diabetic Macular Edema Using Clearside’s Proprietary SCS Microinjector®

Nov 2 2023

Clearside Biomedical Announces Presentations at the American Academy of Ophthalmology 2023 Annual Meeting

Nov 1 2023

Clearside Biomedical Completes Recruitment in ODYSSEY Phase 2b Clinical Trial of CLS-AX in Wet AMD

Oct 31 2023

Clearside Biomedical to Report Third Quarter 2023 Financial Results and Provide Corporate Update on Monday, November 13, 2023

Oct 16 2023

Clearside Biomedical Positive OASIS and Extension Study Data Presented at The Retina Society 56th Annual Scientific Meeting

Oct 4 2023

Clearside Biomedical Announces Advancement of XIPERE® in Asia-Pacific for Suprachoroidal Treatment of Uveitic Macular Edema as Partner Arctic Vision Completes Enrollment in Phase 3 Clinical Trial in China

Oct 3 2023

Clearside Biomedical to Participate in a Panel Discussion at the JonesTrading 2023 Healthcare Summit

Current page 1
Page 2
Page 3
Page 4
Next page
Last page

Email Alerts
Print Page
RSS Feeds
IR Contact

Request Email Alerts

(678) 270-3631
info@clearsidebio.com
CONTACT US

ABOUT US
MANAGEMENT
BOARD OF DIRECTORS
SCIENTIFIC ADVISORY BOARD
PRIVACY POLICY

SCIENCE
SUPRACHOROIDAL SPACE
SCS MICROINJECTOR®
PUBLICATIONS & PRESENTATIONS
Intellectual Property

PRODUCTS
XIPERE™

PIPELINE
CLS-AX
INTEGRIN INHIBITOR
GENE THERAPY
COLLABORATIONS

INVESTORS
IR OVERVIEW
NEWS
EVENTS & PRESENTATIONS
GOVERNANCE
SEC FILINGS
FINANCIAL INFO
RESOURCES

Copyright 2023 © Clearside Biomedical | Website Design and Development by Emma Tang Designs